Stock Information
Scholar Rock Holding Corp (SRRK)
Ticker Symbol: SRRK
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $5,745.30 mil
Piotroski score: 1
PE Ratio: N/A
EPS (TTM): -3.298
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -145.91%
Latest News
-
Scholar Rock To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
Wed, Apr 1, 2026 9:56 AM
-
Wedbush Maintains Outperform on Scholar Rock Holding, Raises Price Target to $58
Wed, Apr 1, 2026 8:38 AM
-
Scholar Rock Holding Corporation (SRRK) Discusses BLA Resubmission for Apitegromab in Spinal Muscular Atrophy and Regulatory Progress Transcript
Tue, Mar 31, 2026 2:22 PM
-
Apellis Pharmaceuticals, Centessa Pharmaceuticals, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
Tue, Mar 31, 2026 9:57 AM
-
Scholar Rock Holding shares are trading higher after the company announced resubmission of its Biologics License Application for apitegromab for the treatment of spinal muscular atrophy to the FDA, with an expected PDUFA date in late September 2026.
Tue, Mar 31, 2026 7:27 AM
-
Scholar Rock Resubmits FDA Biologics License Application For Apitegromab For Spinal Muscular Atrophy, PDUFA Action Date Expected In Late September 2026
Tue, Mar 31, 2026 7:04 AM
-
Scholar Rock: From Manufacturing Hurdle To Commercial Muscle, Maintaining Buy Rating
Sat, Mar 28, 2026 10:23 AM
Key Financials
Financial data not available
